𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polymorphic markers associated with genes responsible for lipid and carbohydrate metabolism disorders and insulin resistance in cancer patients

✍ Scribed by Yu. M. Ulybina; E. N. Imyanitov; D. A. Vasilyev; L. M. Berstein

Book ID
110174624
Publisher
SP MAIK Nauka/Interperiodica
Year
2008
Tongue
English
Weight
210 KB
Volume
42
Category
Article
ISSN
0026-8933

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gemcitabine metabolic and transporter ge
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer
✍ Motofumi Tanaka; Milind Javle; Xiaoqun Dong; Cathy Eng; James L. Abbruzzese; Don πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 226 KB πŸ‘ 3 views

## Abstract ## BACKGROUND: It has not been well established whether genetic variations can be biomarkers for clinical outcome of gemcitabine therapy. The purpose of this study was to identify single nucleotide polymorphisms (SNPs) of gemcitabine metabolic and transporter genes that are associated

Genetic variation and response to morphi
Genetic variation and response to morphine in cancer patients : Catechol-o-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects
✍ Joy R. Ross; Julia Riley; Annie B. Taegetmeyer; Hiroe Sato; Sophy Gretton; Rolan πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 200 KB

## Abstract ## BACKGROUND Pain is a common symptom for patients with cancer, and opioids are the treatment of choice for moderate or severe cancer‐related pain. Central side effects, such as drowsiness, confusion, and hallucinations, can limit the use of opioids in clinical practice. ## METHODS